Understanding Biosimilars 101
Exploring Biosimilars 101 reveals several interesting facts. Michael Rigas, PharmD, focuses on an in-depth review of
Key Takeaways about Biosimilars 101
- Follow along with this simple, animated white board video to learn about
- In this episode, TRC Healthcare editor, *Vickie Danaher, PharmD,* guides listeners through the evolving landscape of ...
- What are
- What is the difference between generic and name-brand drugs, and how can
- In this Quick Guide to
Detailed Analysis of Biosimilars 101
Learn the basics about Regulatory, patient, and provider, United States health care leaders join Presented by Megan Buechel, PharmD on December 13, 2022.
For our third webinar this year, AAIDA's will host our own Medical Advisory Board Chair and speciality pharmacist, Michael Rigas, ...
Stay tuned for more updates related to Biosimilars 101.